Therapy may curb kidney deterioration in patients with rare disorder

Researchers have overcome a biological hurdle to find improved treatments for patients with methylmalonic acidemia. Using genetically engineered mice created for their studies, the team identified a set of biomarkers of kidney damage -- a hallmark of the disorder -- and demonstrated that antioxidant therapy protected kidney function in the mice.View full story